| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |